National Bank of Canada’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.45K | Sell |
366
-1
| -0.3% | -$20 | ﹤0.01% | 2054 |
|
2025
Q1 | $6.66K | Sell |
367
-14
| -4% | -$254 | ﹤0.01% | 1997 |
|
2024
Q4 | $9.63K | Hold |
381
| – | – | ﹤0.01% | 1968 |
|
2024
Q3 | $13K | Hold |
381
| – | – | ﹤0.01% | 1842 |
|
2024
Q2 | $14.9K | Buy |
381
+13
| +4% | +$507 | ﹤0.01% | 1889 |
|
2024
Q1 | $14.7K | Hold |
368
| – | – | ﹤0.01% | 1905 |
|
2023
Q4 | $14.9K | Hold |
368
| – | – | ﹤0.01% | 1902 |
|
2023
Q3 | $10.1K | Hold |
368
| – | – | ﹤0.01% | 1971 |
|
2023
Q2 | $12.5K | Hold |
368
| – | – | ﹤0.01% | 1951 |
|
2023
Q1 | $13.2K | Buy |
368
+366
| +18,300% | +$13.2K | ﹤0.01% | 1927 |
|
2022
Q4 | $89 | Hold |
2
| – | – | ﹤0.01% | 2545 |
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2523 |
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2581 |
|
2022
Q1 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 2618 |
|
2021
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2570 |
|